Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism ofLeishmania amazonensispromastigotes
Authors:
- Karina M. RebelloKRKarina M. Rebello
- Valter V. Andrade-NetoVAValter V. Andrade-Neto
- Aline A. ZumaAZAline A. Zuma
- Maria Cristina M. MottaMMMaria Cristina M. Motta
- Marcus Vinícius N. de SouzaMSMarcus Vinícius N. de Souza
- Geórgia C. AtellaGAGeórgia C. Atella
- Marta H. BranquinhaMarta H. Branquinha
- André L. S. SantosAndré L. S. Santos
- Eduardo Caio Torres-SantosETEduardo Caio Torres-Santos
- Claudia M. D'AVila-LevyCDClaudia M. D'AVila-Levy
Open Access
- 28 May 2018
- journal article
- research article
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 145 (10) , 1304-1310
Abstract
The anti-leishmania effects of HIV peptidase inhibitors (PIs) have been widely reported; however, the biochemical target and mode of action are still a matter of controversy inLeishmaniaparasites. Considering the possibility that HIV-PIs induce lipid accumulation inLeishmania amazonensis, we analysed the effects of lopinavir on the lipid metabolism ofL. amazonensispromastigotes. To this end, parasites were treated with lopinavir at different concentrations and analysed by fluorescence microscopy and spectrofluorimetry, using a fluorescent lipophilic marker. Then, the cellular ultrastructure of treated and control parasites was analysed by transmission electron microscopy (TEM), and the lipid composition was investigated by thin-layer chromatography (TLC). Finally, the sterol content was assayed by gas chromatography–mass spectrometry (GC/MS). TEM analysis revealed an increased number of lipid inclusions in lopinavir-treated cells, which was accompanied by an increase in the lipophilic content, in a dose-dependent manner. TLC and GC–MS analysis revealed a marked increase of cholesterol-esters and cholesterol. In conclusion, lopinavir-induced lipid accumulation and affected lipid composition inL. amazonensisin a concentration–response manner. These data contribute to a better understanding of the possible mechanisms of action of this HIV-PI inL. amazonensispromastigotes. The concerted action of lopinavir on this and other cellular processes, such as the direct inhibition of an aspartyl peptidase, may be responsible for the arrested development of the parasite.Keywords
This publication has 53 references indexed in Scilit:
- Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patientsJournal of Antimicrobial Chemotherapy, 2012
- Lipid Bodies: Inflammatory Organelles Implicated in Host-Trypanosoma cruziInterplay during Innate Immune ResponsesMediators of Inflammation, 2012
- Cholesterol, the central lipid of mammalian cellsCurrent Opinion in Cell Biology, 2010
- Drug targets in LeishmaniaJournal of Parasitic Diseases, 2010
- Lipid Droplets Finally Get a Little R-E-S-P-E-C-TCell, 2009
- Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid DrugsInterdisciplinary Perspectives on Infectious Diseases, 2009
- HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer modelsCurrent Opinion in HIV and AIDS, 2008
- The Relationship between Leishmaniasis and AIDS: the Second 10 YearsClinical Microbiology Reviews, 2008
- Trypan Blue Exclusion Test of Cell ViabilityCurrent Protocols in Immunology, 1997
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959